Study Evaluating the Efficacy and Safety of Desvenlafaxine Tablets in Adult Outpatients With Major Depressive Disorder

NCT00300378 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

480

Enrollment

INDUSTRY

Sponsor class

Conditions

Depressive Disorder, Major

Interventions

DRUG: desvenlafaxine 50 mg
DRUG: desvenlafaxine 100 mg

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer